A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study [0.03%]
一种用于卫生经济证据系统评价文献回顾的机器学习和大型语言模型工具验证研究
Lisa M Bloudek,Allie B Cichewicz,Kush Patel et al.
Lisa M Bloudek et al.
Background: Systematic literature reviews offer high potential for efficiency gains from artificial intelligence (AI), now integrated into several systematic literature review software platforms. Validation studies show a...
A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States [0.03%]
在美国用于治疗代谢功能障碍相关脂肪性肝炎的司美格鲁肽2.4毫克、瑞美昔布80毫克和瑞美昔布100毫克标准护理的成本效益模型
Aidan J McGovern,Frank Cinfio,Roger Luo
Aidan J McGovern
Background: Given the considerable clinical and economic burden posed by non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced fibrosis, there is a substantial demand for effectiv...
Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings [0.03%]
资源匮乏条件下的卫生技术评估机构不确定性经济评价实用指南
Siobhan Botwright,Syarifah Liza Munira,Itamar Megiddo et al.
Siobhan Botwright et al.
Understanding the financial and health consequences if economic evaluation assumptions prove incorrect is essential for managing the risk associated with benefit package decisions, particularly in resource-constrained and overburdened healt...
Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review [0.03%]
肺癌筛查的成本效益及预算影响:系统评价研究
Nuo Chen,Siyuan Wang,Jing Bai et al.
Nuo Chen et al.
Introduction: Clinical trials have demonstrated the benefits of early detection of lung cancer (LC); however, the implementation of national LC screening programs remains under consideration. Economic evaluations provide ...
Comparing User-Written Codes for Performing Economic Evaluations in Stata [0.03%]
比较用户编写的用于在Stata中进行经济评估的代码
Bradley Barker-Jones,Patricia Navvuga,Petra Baji et al.
Bradley Barker-Jones et al.
Background: Several user-written Stata codes exist for trial-based economic evaluations, but they lack assessment and guidance. This study aimed to identify and compare publicly available user-written Stata codes for tria...
Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: A Cost-Effectiveness Analysis [0.03%]
帕金森病吸入型左旋多巴治疗剂管理“开关”现象的成本效益分析
Daniel Evans,Chetan Mistry,Harun Knight et al.
Daniel Evans et al.
Introduction: OFF episodes in Parkinson's disease (PD), where symptoms worsen despite symptomatic treatment, are associated with significant burden on patients, carers and healthcare providers. There is an unmet need for ...
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance [0.03%]
神经发育障碍儿童干预措施的经济评价:实用指南
Jennifer D Zwicker,Ramesh Lamsal,Myla E Moretti et al.
Jennifer D Zwicker et al.
Neurodevelopmental disorders are lifelong conditions with onset in early childhood that impair cognitive, social, behavioural and physical functioning. Their consequences extend beyond healthcare, shaping education, social and community ser...
Endovascular Treatment for Acute Ischemic Stroke: A Methodological Systematic Review of Health Economic Decision Modeling Studies [0.03%]
急性缺血性卒中血管内治疗的卫生经济学决策模型研究系统评价的方法学质量评估
Andreas Beisel,Hans-Helmut König,Judith Dams
Andreas Beisel
Background and objective: Ischemic strokes are one of the main causes for death and disability worldwide and pose a substantial economic burden on healthcare systems. Currently, endovascular treatment is considered one of...
Nadine Henderson,Brittany Darrow,Phill ONeill et al.
Nadine Henderson et al.
Background: The National Institute for Health and Care Excellence (NICE) regularly issues optimised technology appraisal (TA) recommendations, whereby medicines are recommended for a subset of their licensed population. T...
Correction: Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes [0.03%]
订正:用于儿童1型糖尿病筛查策略的患者水平多目标优化模型的建立
Gonçalo Leiria,R Brett McQueen,Conner Jackson et al.
Gonçalo Leiria et al.
Published Erratum
PharmacoEconomics. 2026 Jul 10. DOI:10.1007/s40273-026-01633-0 2026